1Cappuccio FP,D'elia I,Strazzullo P,Miller MA.Quantity and quality of sleep and incidence of type 2 diabetes.Diab Care 2010; 33:414-420.
2Buxton OM,Pavlova M,Reid EW,Wang W,Simonson DC,Adler GK.Sleep restriction for l week reduces insulin sensitivity in healthy men.Diabetes 2010; 59:2126-2133.
3Schmid SM,Hallschmid M,Jauch-Chara K,BandorfN,Born J,Schultes B.Sleep loss alters basal metabolic hormone secretion and modulates the dynamic counterregulatory response to hypoglycemia.J Clin Endocrinol Metab 2007; 92:3044-3051.
4Beihl DA,Liese AD,Haffner SM.Sleep duration as a risk factor for incident type 2 diabetes in a multiethnic cohort.Ann Epidemiol2009; 19:351-357.
5Chao CY,Wu JS,Yang YC,Shih CC,Wang RH,Lu FH,et al.Sleep duration is a potential risk factor for newly diagnosed type 2 diabetes mellitus.Metabolism 2011; 60:799-804.
6Chaput JP,Després JP,Bouchard C,Astrup A,Tremblay A.Sleep duration as a risk factor for the development of type 2 diabetes or impaired glucose tolerance:analyses of the Quebec Family Study.Sleep Med 2009; 10:919-924.
7Tuomilehto H,Peltonen M,Partinen M,Lavigne G,Eriksson JG,Herder C,et al.Sleep duration,lifestyle intervention,and incidence of type 2 diabetes in impaired glucose tolerance:the Finnish Diabetes Prevention Study.Diab Care 2009; 32:1965-1971.
8Hoevenaar-Blom MP,Spijkerman AM,Kromhout D,van den Berg JF,Verschuren WM.Sleep duration and sleep quality in relation to 12-year cardiovascular disease incidence:the MORGEN Study.Sleep 2011; 34:1487-1492.
9Skaer TL,Sclar DA.Economic implications of sleep disorders.Pharmacoeconomics 2010; 28:1015-1023.
10Cho EH,Lee H,Ryu OH,Choi MG,Kim SW.Sleep disturbances and glucoregulation in patients with type 2 diabetes.J Korean Med Sci 2014; 29:243-247.
